44Sc-DOTA-NAPamide

N/A

Report date: 2025/01/26 18:44:07

Base Information

Drug Name44Sc-DOTA-NAPamide
Drug Alias Name44Sc-DOTA-NAPamide (ScanoMed)
ClassificationRadiation-emitting products
Mechanisms of ActionMelanocortin receptor 1 modulators
TargetsMelanocortin receptor 1
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungary
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScanoMed Ltd
China Registration ClassN/A

Develop Information

Active CompaniesScanoMed Ltd
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A